John Lamont

1.7k citations

67 papers · 1.1k indexed · h-index 19

Impact in

Nephrology top 5%
- Acute Kidney Injury Research
Biological Psychiatry

Papers in ⓘ

Nephrology 9
- Chronic Kidney Disease and Diabetes 5
- Acute Kidney Injury Research 4
Cardiology and Cardiovascular Medicine 19
- Cardiovascular Disease and Adiposity 6

Co-authors: Stephen P. Fitzgerald (5 shared papers)Peter Fitzgerald (34 shared papers)Sophie Visvikis‐Siest (22 shared papers)R.I. McConnell (5 shared papers)Bernard Herbeth (8 shared papers)Hind Berrahmoune (6 shared papers)Mary Jo Kurth (17 shared papers)Mark W. Ruddock (20 shared papers)
Journals: Clinical Chemistry and Laboratory Medicine (CCLM) (5 papers)PLoS ONE (4 papers)Scientific Reports (3 papers)International Journal of Molecular Sciences (3 papers)Food and Agricultural Immunology (3 papers)
Partner nations: United Kingdom France Italy

In The Last Decade

John Lamont

66 papers receiving 1.1k citations

Peers

Countries citing papers authored by John Lamont

Since Specialization

Citations

This map shows the geographic impact of John Lamont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lamont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lamont more than expected).

Fields of papers citing papers by John Lamont

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Lamont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lamont. The network helps show where John Lamont may publish in the future.

Co-authors

The 25 scholars most cited alongside John Lamont, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Lamont Line = papers co-authored together John Lamont links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Development of a High-Throughput Automated Analyzer Using Biochip Array Technology Clinical Chemistry ·Stephen P. Fitzgerald, John Lamont, R.I. McConnell, El Ouard Benchikh	2005	134
2	Diagnostic accuracy of heart-type fatty acid–binding protein for the early diagnosis of acute myocardial infarction The American Journal of Emergency Medicine ·C. Geraldine McMahon, John Lamont, Elizabeth Curtin, R.I. McConnell, Martin Crockard, Mary Jo Kurth, Peter Crean, S. P. Fitzgerald	2011	63
3	Epicardial adipocyte hypertrophy: Association with M1-polarization and toll-like receptor pathways in coronary artery disease patients Nutrition Metabolism and Cardiovascular Diseases ·Elena Vianello, Elena Dozio, Francesca Arnaboldi, Monica Gioia Marazzi, Carla Martinelli, John Lamont, Lorenza Tacchini, Alexander Sigrüner, Gerd Schmitz, Massimiliano Marco Corsi Romanelli	2016	62
4	Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases Frontiers in Aging Neuroscience ·Christoffer Rosén, Niklas Mattsson, Per Johansson, Ulf Andréasson, Anders Wallin, Oskar Hansson, John Lamont, Johan Svensson, Kaj Blennow, Henrik Zetterberg	2011	58
5	Automation of biochip array technology for quality results Clinical Chemistry and Laboratory Medicine (CCLM) ·Roisin M Molloy, R. Connell, John Lamont, Stephen P. Fitzgerald	2005	54
6	Biological Determinants of and Reference Values for Plasma Interleukin-8, Monocyte Chemoattractant Protein-1, Epidermal Growth Factor, and Vascular Endothelial Growth Factor: Results from the STANISLAS Cohort Clinical Chemistry ·Hind Berrahmoune, John Lamont, Bernard Herbeth, Peter Fitzgerald, Sophie Visvikis‐Siest	2006	44
7	Serum Total Antioxidant Status, Erythrocyte Superoxide Dismutase and Whole-Blood Glutathione Peroxidase Activities in the Stanislas Cohort: Influencing Factors and Reference Intervals Clinical Chemistry and Laboratory Medicine (CCLM) ·Mohammed Habdous, Bernard Herbeth, Monique Vincent‐Viry, John Lamont, Peters S. Fitzgerald, Sophie Visvikis‐Siest, Gérard Siest	2003	37
8	The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria Cancer ·Funso Abogunrin, Hugh F. O’Kane, Mark W. Ruddock, Michael Stevenson, Cherith N. Reid, Joe M. O’Sullivan, Neil H. Anderson, Declan O’Rourke, Brian Duggan, John Lamont, Ruth Boyd, Peter Hamilton, Thiagarajan Nambirajan, Kate E. Williamson	2011	35
9	A platelet protein biochip rapidly detects an Alzheimer’s disease-specific phenotype Acta Neuropathologica ·Michael Veitinger, Rudolf Oehler, Ellen Umlauf, Roland Baumgartner, Georg Schmidt, Christopher Gerner, Rita Babeluk, Johannes Attems, Goran Mitulović, Eduard Rappold, John Lamont, Maria Zellner	2014	35
10	VEGF-related polymorphisms identified by GWAS and risk for major depression Translational Psychiatry ·Ting Xie, Maria G. Stathopoulou, Fernando de Andrés, Gérard Siest, Helena Murray, Carmen Martín, J. Cobaleda, A. Delgado, John Lamont, E Peñas-LIedó, Adrián LLerena, Sophie Visvikis‐Siest	2017	33
11	Expression of the Receptor for Advanced Glycation End Products in Epicardial Fat: Link with Tissue Thickness and Local Insulin Resistance in Coronary Artery Disease Journal of Diabetes Research ·Elena Dozio, Elena Vianello, Silvia Briganti, John Lamont, Lorenza Tacchini, Gerd Schmitz, Massimiliano Marco Corsi Romanelli	2015	33
12	Angiogenesis related genes NOS3, CD14, MMP3 and IL4R are associated to VEGF gene expression and circulating levels in healthy adults BMC Medical Genetics ·Abdelsalam Saleh, Maria G. Stathopoulou, Sébastien Dadé, Ndeye Coumba Ndiaye, Mohsen Azimi–Nezhad, Helena Murray, Christine Masson, John Lamont, Peter Fitzgerald, Sophie Visvikis‐Siest	2015	29
13	A common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C Journal of Lipid Research ·Maria G. Stathopoulou, Amélie Bonnefond, Ndeye Coumba Ndiaye, Mohsen Azimi–Nezhad, Saïd El Shamieh, Abdelsalam Saleh, Marc Rancier, Gérard Siest, John Lamont, Peter Fitzgerald, Sophie Visvikis‐Siest	2012	29
14	Associations of vascular endothelial growth factor (VEGF) with adhesion and inflammation molecules in a healthy population Cytokine ·Mohsen Azimi–Nezhad, Maria G. Stathopoulou, Amélie Bonnefond, Marc Rancier, Abdelsalam Saleh, John Lamont, Peter Fitzgerald, Ndeye Coumba Ndiaye, Sophie Visvikis‐Siest	2012	28
15	Heritability for Plasma VEGF Concentration in the Stanislas Family Study Annals of Human Genetics ·Hind Berrahmoune, Bernard Herbeth, John Lamont, Christine Masson, Peter Fitzgerald, Sophie Visvikis‐Siest	2006	25
16	Prediction of contrast induced acute kidney injury using novel biomarkers following contrast coronary angiography QJM ·Michael Connolly, M Kinnin, David McEneaney, Ian Menown, Mary Jo Kurth, John Lamont, Neal Morgan, Mark Harbinson	2017	24
17	Standardization of Diagnostic Biomarker Concentrations in Urine: The Hematuria Caveat PLoS ONE ·Cherith N. Reid, Michael Stevenson, Funso Abogunrin, Mark W. Ruddock, Frank Emmert‐Streib, John Lamont, Kate E. Williamson	2012	24
18	Stratifying risk of acute kidney injury in pre and post cardiac surgery patients using a novel biomarker-based algorithm and clinical risk score Scientific Reports ·William T. McBride, Mary Jo Kurth, Gavin McLean, Anna Domanska, John Lamont, Daniel Maguire, Joanne Watt, Peter Fitzgerald, Ian Young, Jijin Joseph, Mark W. Ruddock	2019	22
19	A combined proteomic and genetic analysis of the highly variable platelet proteome: From plasmatic proteins and SNPs Journal of Proteomics ·Michael Veitinger, Ellen Umlauf, Roland Baumgartner, Sigrun Badrnya, Jonny Porter, John Lamont, Christopher Gerner, Christian W. Gruber, Rudolf Oehler, Maria Zellner	2012	18
20	Inter-individual variation of inflammatory markers of cardiovascular risks and diseases Clinical Chemistry and Laboratory Medicine (CCLM) ·Hind Berrahmoune, John Lamont, Peter Fitzgerald, Sophie Visvikis‐Siest	2005	18

About John Lamont

John Lamont is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine, Immunology and Allergy, Immunology and Endocrinology, Diabetes and Metabolism, having authored 67 papers that have together received 1.1k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (7 papers), Cardiovascular Disease and Adiposity (6 papers), Chronic Kidney Disease and Diabetes (5 papers), Bladder and Urothelial Cancer Treatments (5 papers), Alzheimer's disease research and treatments (4 papers), Cardiac Imaging and Diagnostics (4 papers), Acute Kidney Injury Research (4 papers) and Cell Adhesion Molecules Research (4 papers). The work is most often cited by research in Nephrology (89 citations), Biological Psychiatry (25 citations), Cardiology and Cardiovascular Medicine (223 citations), Physiology (176 citations) and Immunology (125 citations). John Lamont has collaborated with scholars based in United Kingdom, France and Italy. Frequent co-authors include Stephen P. Fitzgerald, Peter Fitzgerald, Sophie Visvikis‐Siest, R.I. McConnell, Bernard Herbeth, Hind Berrahmoune, Mary Jo Kurth, Mark W. Ruddock, Maria G. Stathopoulou and Christine Masson. Their work appears in journals such as Clinical Chemistry and Laboratory Medicine (CCLM), PLoS ONE, Scientific Reports, International Journal of Molecular Sciences and Food and Agricultural Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact